(1)
COMPARISON OF OUTCOME IN METFORMIN WITH DAPAGLIFOZIN VERSUS METFORMIN WITH SITAGLIPTIN IN-TERM OF REDUCTION IN HBA1C IN TYPE 2 DIABETES MELLITUS. FMHR 2025, 3 (4), 1069-1073.